H35.381
Toxic maculopathy, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Toxic maculopathy is a condition that affects the macula, the central part of the retina responsible for sharp, detailed vision. When this condition occurs in the right eye, it is classified under ICD-10 code H35.381. The disease results from exposure to toxins that damage the macular tissue, leading to vision impairment. Recognizing the causes, symptoms, and management options can help in early detection and treatment of this eye condition.
Causes & Symptoms
Clinical Causes: Toxic exposure to certain medications (e.g., chloroquine, hydroxychloroquine) Industrial or chemical exposure to eye-damaging substances Prolonged use of drugs with known retinopathic side effects Environmental toxins that accumulate in ocular tissues Unintentional contact with harmful substances in the workplace
Key Symptoms: Gradual loss of central vision in the right eye Distorted or blurred vision when looking at straight lines or objects Difficulty recognizing faces or reading fine print Dark or empty areas in the central visual field Color vision changes or decreased color perception
Diagnostic & Treatment
Diagnosis Path: Diagnosis of toxic maculopathy involves comprehensive eye examination techniques, including visual acuity tests, fundus examination, and imaging studies like optical coherence tomography (OCT). Fluorescein angiography may be used to assess retinal blood flow and damage. A detailed medical history focusing on toxin exposure, medication use, and occupational hazards is crucial for confirming the diagnosis. Early detection relies heavily on ocular screening when patients are exposed to potential toxins, especially those known to impact the retina.
Treatment Protocols: Discontinuation of the offending medication or exposure to harmful chemicals Monitoring of visual function and retinal changes over time Use of nutritional supplements like antioxidants, as recommended by an eye care professional Supportive measures such as low vision aids for visual impairment In some cases, experimental therapies or clinical trials might be considered
Clinical Advice & FAQs
Billing Guidance
Is H35.381 a billable ICD-10 code?
Yes, H35.381 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.381?
Clinical documentation must specify the nature of Toxic maculopathy, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference